News

SEARCH FIRM NEWS

news January 27, 2023

Ashish Talati & Rend Al-Mondhiry quoted in “Is FDA watching heart health supplements in 2023?”

Nutritional Outlook spoke with ATW’s Ashish Talati and Rend Al-Mondhiry about ingredient trends in 2023. Both Ashish and Rend pointed to the trend they are seeing of FDA issuing groups of warning letters in conjunction with a press release, where FDA is sending a broad message to industry regarding these types of claims. Rend noted […]

news January 25, 2023

2023 Illinois Edition of Super Lawyers Recognizes Amin Talati Wasserman’s Rising Stars

Two attorneys in the firm were recognized in the latest edition of Illinois Super Lawyers. Kudos to Natascia Taken and Ashley Rovner-Watson. Amin Talati Wasserman is grateful to have these superstars on our team. Natascia Taken: Food & Drug Ashley Rovner-Watson: Intellectual Property  

news January 6, 2023

FDA Cosmetics Reform is Just Around the Corner – GMPs, Facility Registration, Product Listing, Recall Authority, and More: Meet the Modernization of Cosmetics Regulation Act of 2022

Just before the Christmas holiday, in a scramble to avoid a partial government shutdown, both houses of Congress approved a $1.7 trillion government spending bill. Earlier that week, the Senate had amended the Consolidated Appropriations Act of 2023 (the “Appropriations Bill”) to, among other things, reintroduce the Modernization of Cosmetics Regulations Act of 2022 (“MOCRA”). […]

news January 3, 2023

Matt Orr quoted in “Energy drink stakeholders respond to TINA, UConn Rudd Center complaints”

NutraIngredients-USA asked Matt Orr to comment on complaints by consumer groups over allegations of deceptive and unfair marketing tactics used by the energy drinks industry. Truth in Advertising (TINA) and the UConn Rudd Center for Food Policy & Health focused on “kid-friendly flavors” and packaging tie-ins with candy brands. Matt remarked that TINA is “taking […]

news December 12, 2022

Rend Al-Mondhiry quoted in “Analysis: CBD food industry unlikely to placate FDA” — Natural Products Insider

Rend Al-Mondhiry spoke with Natural Products Insider about FDA’s recent warning letters to companies regarding CBD in food and offered several key takeaways. Rend said that “disease claims seem to be more of an afterthought in these letters. Avoiding disease claims for this [CBD food] category is not going to be enough. She further stated, […]

news November 22, 2022

Online Webinar Now Available: “Advertising to an Aging Population”

Seniors are a powerful consumer demographic who want advertising they can believe and content backed by evidence. In their session, Advertising to an Aging Population, featured as part of the recent online series, “Active Aging: Mastering the Market” by Naturally Informed, ATW partners Lauren Aronson and Matt Orr explained the key ingredients companies need to […]

news November 22, 2022

Abhishek Gurnani quoted in “FDA warning letters target claims to treat cardiovascular disease with supplements” – Natural Products Insider

Abhishek Gurnani spoke with Natural Products Insider about FDA’s warning to companies that sell dietary supplements claiming to cure, mitigate, treat or prevent cardiovascular disease. Abhishek commented: “There is a role for dietary supplements to support cardiovascular health, and there are certainly a number of dietary ingredients that have been studied for their ability to […]

news November 17, 2022

Ivan Wasserman quoted in “FDA’s take down of NMN raises fairness, transparency concerns” – Nutraingredients – USA

Ivan Wasserman discussed the FDA’s recent decision that NMN is not a lawful dietary ingredient with Nutraingredients-USA. As reported, the development further complicates the decision to develop an NDI dossier and is part of an increasingly hard line stance by the Agency on the drug exclusion question. Ivan commented: “First CBD, then NAC, and now […]

What's Now

FDA Cosmetics Reform is Just Around the Corner – GMPs, Facility Registration, Product Listing, Recall Authority, and More: Meet the Modernization of Cosmetics Regulation Act of 2022

Just before the Christmas holiday, in a scramble to avoid a partial government shutdown, both houses of Congress approved a $1.7 trillion government spending bill. Earlier that week, the Senate had amended the Consolidated Appropriations MORE >

see all news >